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ABSTRACT
Purpose: Congenital pulmonary airway malformation (CPAM)－a rare developmental 
anomaly－affects the lower respiratory tract in newborns. By comparing the reliability 
of diagnostic tools and identifying predictive factors for symptoms, we provide com­
prehensive clinical data for the proper management of CPAM.
Methods: We reviewed the medical records of 66 patients with prenatally diagnosed 
CPAM delivered at Severance Children’s Hospital between January 2005 and July 2017.
Results: We enrolled 33 boys and 33 girls. Their mean gestational age and birth weight 
were 38.8 weeks and 3,050 g, respectively. Prenatal ultrasonography and postnatal 
radiography, lung ultrasonography, and chest computed tomography (CT) showed 
inconsistent findings. Chest CT showed superior sensitivity (100%) and positive pre­
dictive value (90%). Among the 66 patients, 59 had postnatally confirmed CPAM, 
three had pulmonary sequestration, one had cystic teratoma, and one had a normal 
lung. Of the 59 patients with CPAM, 21 (35%; mean age, 23.4 months) underwent 
surgery, including 15 who underwent video­assisted thoracoscopy. Twenty­five and 
12 patients exhibited respiratory symptoms at birth and during infancy, respectively. 
Apgar scores and mediastinal shift on radiography were significantly associated with 
respiratory symptoms at birth. However, none of the factors could predict respiratory 
symptoms during infancy.
Conclusion: Radiography or ultrasonography combined with chest CT can confirm 
an unclear or inconsistent lesion. Apgar scores and mediastinal shift on radiography 
can predict respiratory symptoms at birth. However, symptoms during infancy are 
not associated with prenatal and postnatal factors. Chest CT combined with periodic 
symptom monitoring is important for diagnosing and managing patients with pre­
natally diagnosed CPAM and to guide appropriate timing of surgery.
Key Words: Congenital pulmonary airway malformation; Cystic adenomatoid mal­
formation of lung, congenital; Congenit; Thoracic surgery, video­assisted
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INTRODUCTION
Congenital pulmonary airway malformation (CPAM) is a de­
velopmental anomaly of the lungs that occurs in 1 in 10,000 to 
35,000 newborn infants. It originates from the bronchopulmonary 
foregut and is caused by delayed pulmonary development at 4 
to 7 weeks of gestation1). CPAM accounts for 95% of congenital 
cystic pulmonary lesions, most commonly found via prenatal 
screening at 18 to 20 weeks of gestation2). Predicting the presence 
and severity of respiratory symptoms in patients with prenatally 
diagnosed CPAM is difficult, because the use of prenatal ultra­
sound diagnosis and the role of other associated factors in the 
presence and onset of symptoms are unclear3). As patients with 
CPAM can possibly undergo malignant transformation and are 
predisposed to repetitive infection, surgical treatment in the early 
stages has been the current treatment of choice. However, there 
is an on­going controversy regarding elective surgical resection 
in infants with asymptomatic CPAM4).
In this study, we report our experience with the clinical and 
imaging features as well as the postnatal management of new­
borns with prenatally diagnosed CPAM at a single tertiary neo­
natal center over 12 years. By comparing the reliability of imaging 
tools and identifying potential predictive factors associated with 
respiratory symptoms at birth and during infancy, we provide 
comprehensive clinical data that can lead to the proper manage­
ment of CPAM.
MATERIALS AND METHODS 
We conducted a retrospective analysis of the medical records 
of 66 patients with prenatally diagnosed CPAM delivered at 
Severance Children’s Hospital between January 2005 and July 
2017. The histopathological types of CPAM have traditionally 
been based on the Stocker classification5). For newborns with 
prenatally diagnosed CPAM, postnatal chest radiography, lung 
ultrasonography, and/or chest computed tomography (CT) were 
performed. The patients’ respiratory symptoms at birth and du­
ring infancy, history of surgery, surgical methods and outcomes, 
and postoperative pathological findings were reviewed. We also 
analyzed the long­term follow­up data of patients with CPAM at 
the department of pediatrics and thoracic surgery.
The study protocol was approved by the Institutional Review 
Board of Severance Hospital, Yonsei University College of Medi­
cine, Seoul, Korea (4­2019­0137). The requirement for informed 
consent was waived because of the retrospective nature of the 
study and because the analysis used anonymous clinical data. 
Statistical analysis was performed using IBM SPSS Statistics for 
Windows/Macintosh, version 23.0 (IBM Corp., Armonk, NY, 
USA). Noncontinuous variables between the two groups were 
compared using the chi­square test or Fisher’s exact test, and the 
outcomes were represented as percentages. Continuous vari­
ables between the two groups were compared using the two­
sample T­test or Mann­Whitney U­test, and the outcomes were 
represented as mean±standard deviations. All outcomes with P­ 
values <0.05 were considered statistically significant.
RESULTS
1. Characteristics of newborn infants and mothers
The mean gestational age at the time of delivery was 38.8 weeks 
(38.8±1.4), and the mean birth weight was 3,050 g (3,050±460). 
The ratio of boys to girls was 1:1, with 33 patients of each sex. 
The mean final follow­up duration was 48.4 months (48.4± 27.5) 
(Table 1). The mean Apgar scores for 1 and 5 minutes were 6.4 
and 8.0, respectively. The mean age of the mothers was 30.3±4.0 
years. Analysis of the obstetric history revealed only one case of 
accompanying polyhydramnios. The timing of prenatal diagnosis 
of CPAM was at a gestational age of 22.6 weeks (22.6±3.1).
2. Postnatal diagnostic examinations
Chest radiography was performed in all patients at birth. Lung 
Table 1. Characteristics of Newborn Infants with Prenatally 
Diagnosed Congenital Pulmonary Airway Malformation 
Characteristic Total (n=66)
Gestational age (wk) 38.8±1.4
Birth weight (g) 3,050±460
Gender (male/female) 33/33
Apgar score (1 min/5 min) 6.4±1.2/8.0±0.8
Timing of diagnosis (wk) 22.6±3.1
Associated malformation
  Heart 12 (18)
  Kidney 7 (11)
  Gastrointestinal 1 (1)
Respiratory symptoms at birth 25 (38)
Last follow­up (mo) 48.4±27.5
Values are expressed as mean±standard deviation or number (%).
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ultrasonography, chest CT, or both examinations were performed 
at the request of a neonatologist and thoracic surgeon. Among 
patients with prenatally diagnosed CPAM, 15 (23%) showed 
prenatal regression of the lung lesions throughout the serial 
follow­up via prenatal ultrasonography (Figure 1). However, 12 
patients with CPAM and one with pulmonary sequestration were 
diagnosed via postnatal imaging studies (Figure 2). One of these 
patients had no abnormal chest radiography and lung ultrasono­
graphy findings after birth and did not exhibit notable clinical 
symptoms during infancy. However, pulmonary sequestration 
was diagnosed on the basis of routine chest CT performed at the 
age of 1 year. Two patients were lost to follow­up.
Fifty­one patients with prenatally diagnosed CPAM exhibited 
persistent lung lesions until birth. Lung ultrasonography was 
performed in 30 patients. In 21 of these patients, chest CT was 
also performed (Figure 1). Twenty patients who did not undergo 
lung ultrasonography underwent chest CT, except for one patient 
who underwent emergency operation on the day of birth. 
Among the 51 patients, 47 were diagnosed with CPAM, two with 
pulmonary sequestration, and one with mature cystic teratoma 
(Figure 2). However, one patient showed normal findings, as 
confirmed by lung ultrasonography and chest CT. The patient 
with mature cystic teratoma was found to have a mediastinal 
mass, mimicking CPAM, on prenatal ultrasonography. Chest 
radiography performed after birth revealed soft­tissue opacity 
in the lower mediastinum, and ultrasonography demonstrated 
a large lobulated cystic mass at the posterior mediastinum and 
within the peritoneum. Chest CT revealed a lobulated cystic 
mass at the posterior mediastinum and upper abdomen exten­
ding through the diaphragmatic hiatus. Laparoscopic surgery was 
performed, and the pathology was confirmed as mature cystic 
teratoma.
Collectively, among 66 patients with prenatally diagnosed 
CPAM, 59 had CPAM, three had pulmonary sequestration, one 
had cystic teratoma, and one had normal findings, as confirmed 
postnatally. Twenty­two patients (33%) had no visible lung 
lesions on postnatal chest radiography. Of these 22 patients, nine 
underwent lung ultrasonography; among them, five had normal 
ultrasonography findings, but were later diagnosed with mass­
like lung lesions via chest CT. The remaining 44 patients showed 
varying types of lung lesions on chest radiography performed 
after birth: 21 showed opacity, 13 had cystic lesions, seven 
showed hyperinflation, and three had pneumothorax. Although 
13 patients showed normal findings on lung ultrasonography, 
66 Fetuses  with prenatally 
diagnosed CPAM 
15 With prenatal 
regression 
10 With  US 
5 With CT 
5 Without US 
1 With CT 
51 With persistent lesion 
21 Without US 
20 With CT 
1 With surgical 
removal on day 1 
30 With US 
21 With CT 
Figure 1. Flow chart illustrating postnatal diagnostic evaluation. Chest radio-
graphy is performed in all patients who are prenatally diagnosed with congenital 
pulmonary airway malformation (CPAM) at birth. Lung ultrasonography (US), 
chest computed tomography (CT), or both examina tions are performed at the 
request of the neonatologist and thoracic surgeon.
66 Fetuses  with prenatally diagnosed CPAM 
15 With prenatal regression of lesion 
 12 CPAM 
1 Pulmonary sequestration 
2 Follow-up loss 
51 With persistent lesion 
47 CPAM 
2 Pulmonary sequestration 
1 Normal lung 
1 Teratoma 
Figure 2. Flow chart illustrating the selection of the study pop-
ulation. Abbreviation: CPAM, congenital pulmonary airway mal-
formation.
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six were later diagnosed with mass­like lung lesions via chest CT. 
The frequencies of lung lesions on the left and right sides were 
identical in patients with CPAM. Chest radiography and/or lung 
ultrasonography were not adequately reliable for diagnosing 
CPAM because chest CT identified lung lesions in patients with 
prenatally regressed CPAM as well as postnatally negative chest 
radiography or lung ultrasonography findings. The sensitivity 
and positive predictive value of lung ultrasonography, chest 
radiography, and chest CT in the diagnosis of CPAM were 60% 
and 83%, 70% and 88%, and 100% and 90%, respectively (Table 
2). Therefore, chest CT was the most reliable imaging technique 
for diagnosing CPAM.
3. Accompanying malformations
In the entire patient cohort, 12 had cardiac malformations, 
seven had kidney malformations, and one had diaphragmatic 
hernia (Table 1). Cardiac malformations included atrial septal 
defect, patent ductus arteriosus, ventricular septal defect, and 
coarctation of the aorta. Kidney malformations included pelviec­
tasis and hydronephrosis.
4. Respiratory symptoms at birth and during infancy
We sought to identify the factors associated with clinical symp­
toms, including the occurrence of respiratory symptoms, at birth 
and during infancy. Twenty­five patients (38%) exhibited respira­
tory symptoms at birth, and among them, three who exhibited 
pneumothorax required chest tube insertion and 11 required 
invasive ventilator support. The remaining 41 patients (62%) 
were asymptomatic at birth. Respiratory symptoms included 
tachypnea, gasping that required oxygen therapy, intercostal 
retraction, and symptoms that required invasive treatment, such 
as chest tube insertion or intubation. Sex, gestational age, birth 
weight, associated malformations, histologic types of CPAM, 
perinatal regression of CPAM, and location of lung lesion of the 
patient, as well as the age of the mother, were not significantly 
associated with the presence of respiratory symptoms at birth 
(Table 3). The maximum size of the lesion reached during preg­
nancy and timing of diagnosis were also not associated with the 
presence of respiratory symptoms at birth. The Apgar scores at 1 
and 5 minutes (P=0.006 and P=0.012, respectively) and media­
stinal shift on chest radiography (P=0.023) were significantly 
correlated with the respiratory symptoms at birth (Table 3).
Of the 12 patients (17%) with respiratory symptoms during 
infancy, 10 were admitted to the hospital because of pneumonia 
or bronchiolitis. Respiratory symptoms during infancy included 
cough with fever, wheezing, and pneumonia confirmed via chest 
radiography. The mean age at admission was 2.8±2.2 months. No 
significant prenatal and postnatal characteristics could predict 
the presence of respiratory symptoms during infancy.
5. Surgery and complications
Among the 59 patients with CPAM confirmed after birth, 21 
(35%) underwent surgery, and the mean age at surgery was 21 
months (ranging from birth to 54 months). No significant diffe­
rence was observed in patient characteristics between the surgery 
and nonsurgery groups (Table 4). However, in the surgery group, 
Table 2. Comparison of the Diagnostic Accuracy of Imaging 
Techniques in Congenital Pulmonary Airway Malformation 
Variable Lung US Chest radiography Chest CT
Sensitivity (%) 60 70 100
PPV (%) 83 88   90
Abbreviations: US, ultrasonography; CT, computed tomography; PPV, 
positive predictive value.
Table 3. Characteristics of Newborns with Prenatally Diagnosed 
CPAM with or without Respiratory Symptoms at Birth
Characteristic
With 
respiratory 
symptoms 
(n=25)
Without 
respiratory 
symptoms 
(n=41)
P-
value
Male sex 15 (60) 18 (44) 0.210
Gestational age (wk) 38.8±1.9 39.3±1.0 0.057
Birth weight (g), 3,050±482 3,241±44 0.484
Timing of diagnosis (wk) 22.2±2.6 22.9±3.3 0.301
Apgar score 1 min 5.9±1.3 6.8±0.9 0.006
Apgar score 5 min 7.6±0.9 8.2±0.6 0.012
Associated malformations 9 (36) 12 (29) 0.576
Polyhydramnios 1 (4) 0 0.327
Mediastinal shift on chest X­ray 3 (12) 0 0.023
Maximum size (mm) 33.7±15.2 30.2±8.6 0.234
CPAM type 1 15 (60) 15 (37) 0.176
CPAM type 2 6 (24) 19 (46) 0.588
CPAM type 3 1 (4) 3 (7) 0.159
Pulmonary sequestration 2 (8) 1 (2) 0.287
Lesion location, right­side 14 (56) 18 (44) 0.454
Perinatal regression of CPAM 6 (24) 9 (22) 0.850
Age of mother 31.1±3.2 29.3±4.1 0.068
Values are expressed as number (%) or mean±standard deviation.
Abbreviation: CPAM, congenital pulmonary airway malformation.
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the proportion of patients who presented respiratory symptoms 
at birth was higher (48%) than that in the nonsurgery group (34 
%), albeit not statistically significant.
Among the 25 patients presenting respiratory symptoms at 
birth, three underwent early surgery during the neonatal period. 
One patient underwent right lung segmentectomy at 6 days after 
birth because of pneumothorax. Another patient underwent 
right lower lobectomy via video­assisted thoracoscopy (VATS) 
at 21 days after birth because of right pneumothorax. Chest CT 
revealed multicystic masses filled with air (Figure 3A), and the 
surgical and pathological findings were consistent with type 2 
CPAM (Figure 3B).
Another patient, exhibiting right congenital diaphragmatic 
hernia combined with CPAM, underwent bilateral lobectomy 
via thoracotomy and repair of congenital diaphragmatic hernia 
on the day of birth. However, a day after surgery, the patient suc­
cumbed to severe respiratory failure. This patient’s pathological 
findings were consistent with type 1 CPAM (Figure 4). Meanwhile, 
one patient had a huge, multi­segmented, inoperable cystic 
lesion with an air­fluid level in the right thorax, and underwent 
cyst thoracentesis 4 days after birth. Twenty­two days after the 
procedure, the patient succumbed to severe respiratory failure, 
despite chest tube insertion and ventilator care. A pathological 
examination was not performed.
Most of the surgeries were lobectomies performed via VATS 
(15 patients, 71%). Three patients had postoperative complica­
tions, including postoperative fever, chylothorax, and pleural 
effusion requiring thoracentesis. Two patients were readmitted 
because of postoperative pneumonia. Postoperative histological 
examinations confirmed the diagnosis of CPAM. According to 
the Stocker classification (Table 5), nine patients had type 1, 11 
had type 2, and one had type 3 CPAM. Accompanying inflamma­
tion was observed in three patients.
The mean follow­up duration of the 21 patients who under­
went surgery was 46.6 months. Among the 21 patients, four 
were hospitalized, and the mean age at hospitalization was 2.3 
months. Most of these patients were admitted because of pneu­
monia within 6 months of age, and one patient was hospitalized 
because of mycoplasma pneumonia at the age of 35 months.
DISCUSSION
Herein, we have reported our experience with CPAM over 12 
years at a tertiary center. A strength of this study is that we com­
pared imaging tools and attempted to identify various potential 
A 
B 
Figure 3.  Clinical findings of a patient with type 2 congenital pul-
monary airway malformation. (A) Chest computed tomography 
shows an approximately 5.1×2.8×5.3-cm-sized multicystic mass 
filled with air in the right lower lobe, mainly at the superior and 
posterior basal segments of the right lower lobe. (B) The fresh 
specimen consists of a product of video-assisted thoracoscopy-
assisted pneumonectomy, including the right lung. The specimen 
shows multiple uniform cysts. However, no definite mass-like 
lesion is observed, which is consistent with type 2 congenital pul-
monary airway malformation. 
Table 4. Comparison of the Surgery and Nonsurgery Groups of 
Patients with CPAM
Characteristic
Surgery
(n=21)
Nonsurgery
(n=38)
P-
value
Gestational age (wk) 38.9±2.0 39.4±1.1 0.205
Birth weight (g) 3,100±548 3,260±364 0.196
Timing of diagnosis (wk) 21.9±2.9 22.6±2.3 0.305
Apgar score 1 min 6.5±1.3 6.4±1.1 0.889
Apgar score 5 min 8.1±1.1 7.9±0.7 0.991
Associated malformation 7 (33) 14 (37) 0.620
Polyhydramnios 0 1 (3) 0.462
Maximum size (mm) 33.8±11.8 30.6±12.1 0.339
CPAM type 1 9 (43) 21 (55) 0.507
CPAM type 2 11 (52) 14 (37) 0.837
CPAM type 3 1 (5) 3 (8) 0.483
Symptom at birth 10 (48) 13 (34) 0.230
Values are expressed as mean±standard deviation or number (%).
Abbreviation: CPAM, congenital pulmonary airway malformation.
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predictive factors associated with the occurrence of respiratory 
symptoms at birth and during infancy, which are essential for 
postnatal management. Since the diagnosis and management of 
CPAM remain controversial, by reviewing many patients over a 
long term, we aimed to provide comprehensive clinical data on 
CPAM that could lead to its proper management.
CPAM generally occurs in the unilateral form, but exhibits 
higher incidence on the right side6). It may be accompanied by 
excessive amniotic fluid, nonimmune fetal hydrops, ascites, and 
mediastinal shift, as well as other structural anomalies. However, 
CPAM is not associated with chromosomal abnormalities7). In 
our study, the frequency of CPAM was identical between the left 
and right lungs. Polyhydramnios was observed; however, it was 
not significantly correlated with the clinical outcome. No patients 
had chromosomal abnormalities. The histopathological types of 
CPAM have traditionally been based on the Stocker classification 
5). This classification was based on the histological and morpho­
logical findings of lung lesions obtained via surgery. The original 
classification initially included three types of CPAM (types 1, 2, 
and 3), and types 0 and 4 were added later5,8). Type 1 is the most 
common type. However, in this study, type 2 accounted for the 
highest proportion (11/21, 52.4%), and no patient had type 0 or 4.
The diagnosis of CPAM requires a multidisciplinary approach 
involving obstetricians, radiologists, pediatricians, surgeons, and 
pathologists9). As ultrasonography technology has developed, 
the sensitivity of both prenatal and postnatal diagnosis of CPAM 
has been increasing10). One study reported that the prenatal diag­
nosis rate of CPAM was as high as 85.7% over 8 years of retro­
spec tive assessment11). Although the sensitivity and specificity of 
prenatal magnetic resonance imaging is as high as 95%, prenatal 
ultrasonography is the most commonly used diagnostic method 
12). Lesions may grow until 25 to 28 weeks of gestation, but may 
partially regress during the third trimester of pregnancy13). How­
ever, the regression of lesions observed under prenatal ultrasono­
graphy may not result in complete loss of the lesion14). In this 
study, although 15 patients had regression of their lesions, 13 
of them displayed lesions after birth. Thus, even if the lesion re­
gresses during prenatal screening, postnatal imaging is essential 
for the accurate diagnosis of CPAM. In a previous study assessing 
26 patients with prenatally diagnosed CPAM, chest CT was highly 
sensitive and showed a good positive predictive value that was 
consistent with our results15). Prenatal ultrasonography, post­
natal chest radiography, or lung ultrasonography alone is not 
adequately reliable to diagnose CPAM or its complete regression 
16). We suggest chest CT for confirming the diagnosis of CPAM, 
considering its high sensitivity and positive predictive value.
Respiratory symptoms observed immediately after birth in 
patients with prenatally diagnosed CPAM are extremely diverse, 
and may necessitate mechanical ventilation or immediate 
surgical intervention. Identifying the risk factors for respiratory 
symptoms allows the medical staff to provide detailed and precise 
consultation to the caregivers, as well as adequate treatment to 
the patients as early as possible. Moreover, such infants should 
preferably be delivered at medical centers with neonatal intensive 
care units. A previous study suggested that a high CPAM to 
volume ratio (CVR), excessive amniotic fluid, and the presence 
of ascites are good prognostic factors for respiratory symptoms14). 
A 
B 
Figure 4.  Pathological findings of a patient with type 1 congenital 
pulmonary airway malformation. (A) Surgical specimen from the 
right lung mass measuring 2.5×1.5×1 cm. (B) A pathological an-
alysis reveals multiple cysts in the lung parenchyma, which is con-
sistent with type 1 congenital pulmonary airway malformation.
Table 5. The Revised Classification of Stocker
Type 0 Type 1 Type 2 Type 3 Type 4
Frequency (%) 1–3 60–70 15–20 5–10 15
Site of development Tracheao­bronchial Bronchial/bronchiolar Bronchiolar Bronchiolar/alveolar Distal acinar
Cyst size (cm) 0.5 2–10 <2–2.5 <0.2 Vary up to 7
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More specifically, CVR ≥1.6 was reported to increase the risk of 
fetal hydrops17). Much attention has been drawn to identifying 
prognostic factors predicting respiratory outcomes, such as con­
tralateral lung volume per thoracic volume and the incidence of 
mediastinal shift18). However, many studies failed to identify the 
prognostic factors predicting the respiratory symptoms in patients 
with CPAM19). In this study, multiple factors were analyzed to 
identify the prognostic factors for respiratory symptoms at birth 
and during infancy. CVR was excluded because it was not rou­
tinely measured in all examinations. Instead, we compared the 
maximum size of the lesion by measuring its largest dimension 
reached during pregnancy. In our study, the Apgar scores at 1 
and 5 minutes and mediastinal shift on chest radiography were 
significantly associated with respiratory symptoms at birth. Other 
factors were found not to be significant.
Different opinions exist regarding the treatment of CPAM. For 
prenatal treatment, thoracoamniotic shunt or multiple courses of 
antenatal betamethasone for high­risk fetal CPAM are considered 
effective20,21). In our study, no patients had received prenatal in­
tervention. Moreover, the standard for postnatal treatment has 
not yet been established. If the patient is symptomatic, surgical 
treatment is recommended20). The symptoms include infection, 
pulmonary hemorrhage, pneumothorax, respiratory difficulty, 
and malignant transformation. Pneumonectomy is the most 
commonly used surgical treatment for patients with CPAM, and 
it has a high success rate11,22). A previous study that assessed 1,120 
infants demonstrated that the thoracoscopic approach induced 
fewer complications and resulted in shorter hospitalization23). In 
neonates, thoracoscopic intervention may be difficult because of 
the limited operative space within their small bodies24). However, 
minimal­access surgery is becoming widespread, and recently 
published series have reported increased utilization of VATS 
from 32.2% in 2008 to 48.2% in 201423). In our study, 15 patients 
(68%) underwent VATS, with a high success rate; therefore, we 
confirm that thoracoscopic surgery can be performed both safely 
and effectively.
There is an on­going debate about surgical interventions per­
formed in asymptomatic newborn patients. The risk of CPAM 
lesions becoming symptomatic in the first 5 years is less than 
5%4). However, even for asymptomatic patients, the possibility of 
repeated infection and malignant transformation are the reasons 
for pneumonectomy, which may outweigh the benefits of con­
servative management. CPAM can occasionally be a cystic mal­
formation, and it may be a pleuropulmonary blastoma induced 
by DICER1 mutation, albeit rarely (with an estimated incidence 
of 1 in 300,000)20,25). During follow­up, as infants and children are 
inevitably and repeatedly exposed to radiation from radiological 
studies, the European Academic Society suggests that only 
physical examination is required for lesions that are asympto­
matic and stable until the patient becomes an adult26). However, 
there are concerns suggesting that in the absence of surgical 
resection, patients and families may experience continuous and 
unnecessary stress throughout the long­term follow­up process 
20). A previous study reported that approximately 25% of asympto­
matic patients with CPAM eventually develop symptoms at an 
average age of 6 to 7 months, which is different from our findings 
(2.8±2.2 months)19). Our study was performed at a tertiary center 
to which patients with high­risk CPAM are referred and where 
a high proportion of respiratory symptoms are seen at birth; 
these factors could have accounted for the shorter average onset 
time of symptoms observed in our study than in other studies. 
Very few previous studies performed long­term follow­ups in 
pediatric patients who underwent early surgical treatment. At 
our center, the mean follow­up duration of the 21 patients who 
underwent surgery was 46.6 months.
A limitation of this study is that it was performed retrospectively, 
and different obstetric specialists were involved in the prenatal 
ultrasound examination. Furthermore, although our center 
aimed to apply an identical treatment protocol for all patients, 
different thoracic surgeons were involved in the treatment of 
patients and the treatment period varied according to the se­
verity of the patients’ symptoms. Despite these limitations, this 
study provides meaningful experiences because patients with 
prenatally diagnosed CPAM underwent long­term follow­ups 
and were treated at a single tertiary center.
Overall, this study provides comprehensive clinical data on 
prenatal and postnatal clinical characteristics, diagnostic ima­
ging, respiratory symptoms, treatment, and long­term follow­
up of infants with prenatally diagnosed CPAM at a single tertiary 
center. Prenatal and postnatal ultrasonography or chest radio­
graphy alone provided unreliable diagnostic accuracy. They 
showed lower sensitivity and positive predictive value in the 
diag nosis of CPAM than did chest CT (with a sensitivity of 100% 
and positive predictive value of 90%). In case of unclear or incon­
sistent findings on ultrasonography or radiography, chest CT 
can be a valuable diagnostic tool for confirmation. Low Apgar 
scores and mediastinal shift on radiography can be predictive 
factors for respiratory symptoms at birth. However, symptoms 
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during infancy were not associated with prenatal and postnatal 
factors. Therefore, chest CT combined with periodic monitoring 
of cli nical symptoms is important for the proper diagnosis and 
mana gement of patients with prenatally diagnosed CPAM and to 
guide appropriate timing of surgery.
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